171 related articles for article (PubMed ID: 28017833)
1. Protein Palmitoylation by ZDHHC13 Protects Skin against Microbial-Driven Dermatitis.
Chen LY; Yang-Yen HF; Tsai CC; Thio CL; Chuang HL; Yang LT; Shen LF; Song IW; Liu KM; Huang YT; Liu FT; Chang YJ; Chen YT; Yen JJY
J Invest Dermatol; 2017 Apr; 137(4):894-904. PubMed ID: 28017833
[TBL] [Abstract][Full Text] [Related]
2. Palmitoyl Acyltransferase Activity of ZDHHC13 Regulates Skin Barrier Development Partly by Controlling PADi3 and TGM1 Protein Stability.
Chen LY; Lin KR; Chen YJ; Chiang YJ; Ho KC; Shen LF; Song IW; Liu KM; Yang-Yen HF; Chen YJ; Chen YT; Liu FT; Yen JJY
J Invest Dermatol; 2020 May; 140(5):959-970.e3. PubMed ID: 31669413
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous atopic dermatitis in mice with a defective skin barrier is independent of ILC2 and mediated by IL-1β.
Schwartz C; Moran T; Saunders SP; Kaszlikowska A; Floudas A; Bom J; Nunez G; Iwakura Y; O'Neill L; Irvine AD; McKenzie ANJ; Ogg G; Walsh PT; Demengeot J; Fallon PG
Allergy; 2019 Oct; 74(10):1920-1933. PubMed ID: 30937919
[TBL] [Abstract][Full Text] [Related]
4. IL-33-Induced Atopic Dermatitis-Like Inflammation in Mice Is Mediated by Group 2 Innate Lymphoid Cells in Concert with Basophils.
Imai Y; Yasuda K; Nagai M; Kusakabe M; Kubo M; Nakanishi K; Yamanishi K
J Invest Dermatol; 2019 Oct; 139(10):2185-2194.e3. PubMed ID: 31121178
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.
Kaesler S; Volz T; Skabytska Y; Köberle M; Hein U; Chen KM; Guenova E; Wölbing F; Röcken M; Biedermann T
J Allergy Clin Immunol; 2014 Jul; 134(1):92-9. PubMed ID: 24698321
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of atopic dermatitis.
Bonness S; Bieber T
Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):382-6. PubMed ID: 17873576
[TBL] [Abstract][Full Text] [Related]
7. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice.
Imai Y; Yasuda K; Sakaguchi Y; Haneda T; Mizutani H; Yoshimoto T; Nakanishi K; Yamanishi K
Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13921-6. PubMed ID: 23918359
[TBL] [Abstract][Full Text] [Related]
8. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.
Chen L; Overbergh L; Mathieu C; Chan LS
Clin Exp Allergy; 2008 Aug; 38(8):1367-80. PubMed ID: 18489026
[TBL] [Abstract][Full Text] [Related]
9. The role of interleukin-17 in mouse models of atopic dermatitis and contact dermatitis.
Heo WI; Lee KE; Hong JY; Kim MN; Oh MS; Kim YS; Kim KW; Kim KE; Sohn MH
Clin Exp Dermatol; 2015 Aug; 40(6):665-71. PubMed ID: 25684357
[TBL] [Abstract][Full Text] [Related]
10. [The role of the innate immune system in atopic dermatitis].
Volz T; Kaesler S; Skabytska Y; Biedermann T
Hautarzt; 2015 Feb; 66(2):90-5. PubMed ID: 25633721
[TBL] [Abstract][Full Text] [Related]
11. Immunologic aspects of atopic dermatitis.
Lipozencić J; Pastar Z; Kulisić SM; Pavić I
Acta Dermatovenerol Croat; 2009; 17(3):226-34. PubMed ID: 19818224
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes.
Rebane A; Runnel T; Aab A; Maslovskaja J; Rückert B; Zimmermann M; Plaas M; Kärner J; Treis A; Pihlap M; Haljasorg U; Hermann H; Nagy N; Kemeny L; Erm T; Kingo K; Li M; Boldin MP; Akdis CA
J Allergy Clin Immunol; 2014 Oct; 134(4):836-847.e11. PubMed ID: 24996260
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of peptidoglycan recognition proteins on experimental atopic and contact dermatitis mediated by Treg and Th17 cells.
Park SY; Gupta D; Kim CH; Dziarski R
PLoS One; 2011; 6(9):e24961. PubMed ID: 21949809
[TBL] [Abstract][Full Text] [Related]
14. Recent developments in atopic dermatitis.
Peng W; Novak N
Curr Opin Allergy Clin Immunol; 2014 Oct; 14(5):417-22. PubMed ID: 25090248
[TBL] [Abstract][Full Text] [Related]
15. Profile of skin barrier proteins and cytokines in adults with atopic dermatitis.
Orfali RL; Zaniboni MC; Aoki V
G Ital Dermatol Venereol; 2017 Apr; 152(2):140-147. PubMed ID: 27982552
[TBL] [Abstract][Full Text] [Related]
16. Differential Features between Chronic Skin Inflammatory Diseases Revealed in Skin-Humanized Psoriasis and Atopic Dermatitis Mouse Models.
Carretero M; Guerrero-Aspizua S; Illera N; Galvez V; Navarro M; García-García F; Dopazo J; Jorcano JL; Larcher F; del Rio M
J Invest Dermatol; 2016 Jan; 136(1):136-45. PubMed ID: 26763433
[TBL] [Abstract][Full Text] [Related]
17. Zdhhc13-dependent Drp1 S-palmitoylation impacts brain bioenergetics, anxiety, coordination and motor skills.
Napoli E; Song G; Liu S; Espejo A; Perez CJ; Benavides F; Giulivi C
Sci Rep; 2017 Oct; 7(1):12796. PubMed ID: 29038583
[TBL] [Abstract][Full Text] [Related]
18. New insights in the pathogenesis of atopic dermatitis.
Ong PY
Pediatr Res; 2014 Jan; 75(1-2):171-5. PubMed ID: 24192701
[TBL] [Abstract][Full Text] [Related]
19. Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications.
Czarnowicki T; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol Pract; 2014; 2(4):371-9; quiz 380-1. PubMed ID: 25017523
[TBL] [Abstract][Full Text] [Related]
20. Innate immunity in atopic dermatitis.
Mrabet-Dahbi S; Maurer M
Curr Probl Dermatol; 2011; 41():104-111. PubMed ID: 21576951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]